Net sales of this segment increased by $2 million, or 4%, and $6 million, or 6% for the three and six months ended June 30, 2019 when compared to the same periods in 2018, driven primarily by an increase in sales in our emerging businesses.
Net sales for the three and six months ended June 30, 2019 were $2,940 million and $5,752 million, compared to $2,747 million and $5,247 million, respectively, during the same periods in 2018.
Net income increased by $3 million, or 5%, and $6 million, or 5% for the three and six months ended June 30, 2019, primarily driven by the increase in sales outlined above.
In the three and six months ended June 30, 2019, gross margin decreased by $7 million and 1% and increased by $137 million or 7%, respectively.
Net cash provided by operating activities decreased by $911 million in the six months ended June 30, 2019, when compared to the same period in the prior year.
Net sales in the Optical Communications segment increased by $67 million, or 7%, and $245 million, or 13%, respectively, for the three and six months ended June 30, 2019.
Net sales in the Life Sciences segment increased by $15 million, or 6%, and $26 million, or 5%, respectively, for the three and six months ended June 30, 2019.
Net income increased by $9 million, or 29%, and $13 million, or 22%, for the three and six months ended June 30, 2019, respectively.
Net income increased by $11 million, or 20%, and $14 million, or 13%, for the three and six months ended June 30, 2019, respectively.
Net income increased by $8 million, or 5%, and $41 million, or 16%, respectively, for the three and six months ended June 30, 2019.
In the Optical Communications segment, we expect sales to increase by a low-to-mid-single digit percentage, including the impact of a full year of sales from the acquisition of CMD.
Net cash used in investing activities decreased by $721 million in the six months ended June 30, 2019 when compared to the same period last year, primarily resulting from the absence of acquisition costs in the current period.
Automotive product sales increased $31 million and $55 million for the three and six months ended June 30, 2019, due to continued sales growth of gas particulate filters.
Life Sciences sales increased by $15 million and $26 million, respectively.
The acquisition of CMD, which took place during the second quarter of 2018, also contributed to sales growth for both periods.
Net sales in the Optical Communications segment increased $67 million and $245 million, respectively.
In the third quarter, Optical Communications sales are expected to decrease by low-single digits on a year-over-year basis.Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.